Forteo and Eye discharge - a phase IV clinical study of FDA data

Summary:

Eye discharge is reported as a side effect among people who take Forteo (teriparatide recombinant human), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Synthroid, and have Bone disorder.

The phase IV clinical study analyzes which people have Eye discharge when taking Forteo. It is created by eHealthMe based on reports of 126,656 people who have side effects when taking Forteo from the FDA, and is updated regularly.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

What is Eye discharge?

Eye discharge is found to be associated with 690 drugs and 802 conditions by eHealthMe. Check the latest studies of Eye discharge.

On Jul, 20, 2026

126,656 people reported to have side effects when taking Forteo.
Among them, 37 people (0.03%) have Eye discharge.

Among these 37 people:

How long have people been on Forteo when they have Eye discharge? *

What is the gender of people who have Eye discharge when taking Forteo? *

female: 97.3 %
male: 2.7 %

What is the age of people who have Eye discharge when taking Forteo? *

What are other drugs people take besides Forteo? *

What are other side effects people have besides Eye discharge? *

Eye Disorder: 9 people, 24.32%
Nausea (feeling of having an urge to vomit): 9 people, 24.32%
Joint Pain: 8 people, 21.62%
Muscle Cramps (painful sensations caused by muscle contraction): 7 people, 18.92%
Visual Impairment: 7 people, 18.92%
Dizziness: 7 people, 18.92%
Fatigue (feeling of tiredness): 7 people, 18.92%
Eye Irritation: 6 people, 16.22%
Pain: 6 people, 16.22%
Cough: 6 people, 16.22%

What are the existing conditions these people have? *

Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 2.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
Pain: 1 person, 2.70%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 2.70%
Drug Intolerance (drug sensitivity): 1 person, 2.70%
Diabetes: 1 person, 2.70%
Bone Disorder: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Forteo and have Eye discharge?

- Check whether Eye discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Forteo:

Forteo (127,076 reports)

Eye discharge treatments and more:

Eye discharge (10,525 reports)

How severe was Eye discharge and when was it recovered:

Eye discharge in Forteo

Expand to all the drugs that have ingredients of teriparatide recombinant human:

Eye discharge and drugs with ingredients of teriparatide recombinant human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Forteo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye discharge:

Eye discharge (690 drugs)

Browse all the conditions that are associated with Eye discharge:

Eye discharge (802 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on teriparatide recombinant human (the active ingredients of Forteo) and Forteo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.